These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 39212993)

  • 21. A qualitative analysis of barriers to opioid agonist treatment for racial/ethnic minoritized populations.
    Husain JM; Cromartie D; Fitzelle-Jones E; Brochier A; Borba CPC; Montalvo C
    J Subst Abuse Treat; 2023 Jan; 144():108918. PubMed ID: 36403456
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Responses among substance abuse treatment providers to the opioid epidemic in the USA: Variations in buprenorphine and methadone treatment by geography, operational, and payment characteristics, 2007-16.
    Yang JC; Roman-Urrestarazu A; Brayne C
    PLoS One; 2020; 15(3):e0229787. PubMed ID: 32126120
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Help Is on the Way: Medicare Coverage of Opioid Treatment Programs.
    Felix C; Sharfstein JM; Olsen Y
    J Am Geriatr Soc; 2020 Mar; 68(3):637-640. PubMed ID: 31825528
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patterns in admission delays to outpatient methadone treatment in the United States.
    Gryczynski J; Schwartz RP; Salkever DS; Mitchell SG; Jaffe JH
    J Subst Abuse Treat; 2011 Dec; 41(4):431-9. PubMed ID: 21821378
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Methadone's Resurgence in Bridging the Treatment Gap in the Overdose Crisis: Position Statement of AMERSA, Inc (Association for Multidisciplinary Education, Research, Substance Use, and Addiction).
    Suen LW; Incze M; Simon C; Englander H; Bratberg J; Groves Scott G; Winograd R
    Subst Use Addctn J; 2024 Jul; 45(3):337-345. PubMed ID: 38804606
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Methadone and buprenorphine treatments in patients with schizophrenia.
    Dervaux A; Plancke L; Amariei A; Trouiller P; Tahon M; Martinetti MP; Naassila M; Cottencin O; Danel T
    Schizophr Res; 2019 Jul; 209():286-288. PubMed ID: 31101511
    [No Abstract]   [Full Text] [Related]  

  • 27. Addressing Racial And Ethnic Disparities In The Use Of Medications For Opioid Use Disorder.
    Andraka-Christou B
    Health Aff (Millwood); 2021 Jun; 40(6):920-927. PubMed ID: 34097509
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Racial and Ethnic Disparities in Opioid Use Among US Adults With Back Pain.
    King C; Liu X
    Spine (Phila Pa 1976); 2020 Aug; 45(15):1062-1066. PubMed ID: 32675613
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TIME TO REVISIT UNEVEN POLICY IN THE UNITED STATES FOR MEDICATION FOR OPIOID USE DISORDER DURING COVID-19.
    Pena E; Ahmed S
    Addiction; 2020 Oct; 115(10):1978-1979. PubMed ID: 32447795
    [No Abstract]   [Full Text] [Related]  

  • 30. Innovations in efforts to expand treatment for opioid use disorder.
    Sigmon SC
    Prev Med; 2019 Nov; 128():105818. PubMed ID: 31445112
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Trends and Disparities in Initiation of Buprenorphine in US Emergency Departments, 2013-2022.
    Chhabra N; Smith D; Dickinson G; Caglianone L; Taylor RA; D'Onofrio G; Karnik NS
    JAMA Netw Open; 2024 Sep; 7(9):e2435603. PubMed ID: 39325455
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gender-specific predictors of methadone treatment outcomes among African Americans at an urban clinic.
    Lister JJ; Brown S; Greenwald MK; Ledgerwood DM
    Subst Abus; 2019; 40(2):185-193. PubMed ID: 30888262
    [No Abstract]   [Full Text] [Related]  

  • 33. Individual and Health Policy Factors Associated With Positive Heroin and Opioid Treatment Response: United States, 2018.
    Pro G; Hayes C; Brown CC; Goree J; Zaller N
    Am J Public Health; 2022 Feb; 112(S1):S66-S76. PubMed ID: 35143268
    [No Abstract]   [Full Text] [Related]  

  • 34. Barriers to retention in methadone maintenance therapy among people who inject drugs in Bangkok, Thailand: a mixed-methods study.
    Hayashi K; Ti L; Ayutthaya PPN; Suwannawong P; Kaplan K; Small W; Kerr T
    Harm Reduct J; 2017 Sep; 14(1):63. PubMed ID: 28882155
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Racial and ethnic disparities in medication for opioid use disorder access, use, and treatment outcomes in Medicare.
    Gibbons JB; McCullough JS; Zivin K; Brown ZY; Norton EC
    J Subst Use Addict Treat; 2024 Feb; 157():209271. PubMed ID: 38135120
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Medication Treatment of Adolescent Opioid Use Disorder in Primary Care.
    Carney BL; Hadland SE; Bagley SM
    Pediatr Rev; 2018 Jan; 39(1):43-45. PubMed ID: 29292291
    [No Abstract]   [Full Text] [Related]  

  • 37. Treatment retention, return to use, and recovery support following COVID-19 relaxation of methadone take-home dosing in two rural opioid treatment programs: A mixed methods analysis.
    Hoffman KA; Foot C; Levander XA; Cook R; Terashima JP; McIlveen JW; Korthuis PT; McCarty D
    J Subst Abuse Treat; 2022 Oct; 141():108801. PubMed ID: 35589443
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Methadone-Involved Overdose Deaths in the US Before and After Federal Policy Changes Expanding Take-Home Methadone Doses From Opioid Treatment Programs.
    Jones CM; Compton WM; Han B; Baldwin G; Volkow ND
    JAMA Psychiatry; 2022 Sep; 79(9):932-934. PubMed ID: 35830198
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Racial and Ethnic Disparities in Maternal and Infant Outcomes Among Opioid-Exposed Mother-Infant Dyads in Massachusetts (2017-2019).
    Peeler M; Gupta M; Melvin P; Bryant AS; Diop H; Iverson R; Callaghan K; Wachman EM; Singh R; Houghton M; Greenfield SF; Schiff DM
    Am J Public Health; 2020 Dec; 110(12):1828-1836. PubMed ID: 33058701
    [No Abstract]   [Full Text] [Related]  

  • 40. COVID-19-related policy changes for methadone take-home dosing: A multistate survey of opioid treatment program leadership.
    Levander XA; Pytell JD; Stoller KB; Korthuis PT; Chander G
    Subst Abus; 2022; 43(1):633-639. PubMed ID: 34666636
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.